Immuneering (IMRX) Non-Current Assets (2020 - 2026)
Immuneering's Non-Current Assets came in at $44.06 million for Q2 2026, up 257.3% from $12.33 million a year earlier but down 17.5% from the prior quarter.
Immuneering (IMRX) Non-Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, Immuneering's Non-Current Assets was $55.74 million, up 324.6% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 140.6% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $13.13 million in FY2024 (-2.8%), $13.5 million in FY2023 (-0.9%), $13.62 million in FY2022 (-5.2%) and $14.37 million in FY2021.
- The five-year range for quarterly Non-Current Assets is $10.73 million (Q3 2021) to $55.74 million (Q4 2025).
- Year-over-year, Non-Current Assets has increased for three consecutive quarters, with growth averaging 110.2% over the last eight quarters.
- The fastest year-over-year change in Non-Current Assets over five years came in Q2 2022 (growth of 702.4%), and the weakest in Q3 2025 (a decline of 10.1%).
- Business Quant data shows IMRX's Non-Current Assets at $53.4 million (Q1 2026), $55.74 million (Q4 2025) and $11.95 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Immuneering | 236.47 Mn | -470.52 Mn | - | 44.06 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.06 Mn |
| Mar 31, 2026 | 53.40 Mn |
| Dec 31, 2025 | 55.74 Mn |
| Sep 30, 2025 | 11.95 Mn |
| Jun 30, 2025 | 12.33 Mn |
| Mar 31, 2025 | 12.48 Mn |
| Dec 31, 2024 | 13.13 Mn |
| Sep 30, 2024 | 13.30 Mn |
| Jun 30, 2024 | 13.40 Mn |
| Mar 31, 2024 | 13.54 Mn |
| Dec 31, 2023 | 13.50 Mn |
| Sep 30, 2023 | 13.30 Mn |
| Jun 30, 2023 | 13.39 Mn |
| Mar 31, 2023 | 13.46 Mn |
| Dec 31, 2022 | 13.62 Mn |
| Sep 30, 2022 | 13.67 Mn |
| Jun 30, 2022 | 12.88 Mn |
| Mar 31, 2022 | 12.92 Mn |
| Dec 31, 2021 | 14.37 Mn |
| Sep 30, 2021 | 10.73 Mn |
Immuneering Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=IMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();